These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38141419)

  • 1. Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
    Bender C; Müller P; Tondello C; Horn J; Holdener M; Lasch S; Bayer M; Pfeilschifter JM; Tacke F; Ludwig A; Hansmann ML; Döring C; Hintermann E; Christen U
    J Autoimmun; 2024 Feb; 143():103161. PubMed ID: 38141419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes.
    Bender C; Christen S; Scholich K; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    Diabetes; 2017 Jan; 66(1):113-126. PubMed ID: 27797910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11c
    Sandor AM; Lindsay RS; Dyjack N; Whitesell JC; Rios C; Bradley BJ; Haskins K; Serreze DV; Geurts AM; Chen YG; Seibold MA; Jacobelli J; Friedman RS
    Front Immunol; 2019; 10():99. PubMed ID: 30766536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
    Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
    J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
    Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
    PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
    Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.
    Cardozo AK; Proost P; Gysemans C; Chen MC; Mathieu C; Eizirik DL
    Diabetologia; 2003 Feb; 46(2):255-66. PubMed ID: 12627325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets.
    Hu C; Ding H; Li Y; Pearson JA; Zhang X; Flavell RA; Wong FS; Wen L
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11318-23. PubMed ID: 26305961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of chemokines in murine and human type 1 diabetes.
    Sarkar SA; Lee CE; Victorino F; Nguyen TT; Walters JA; Burrack A; Eberlein J; Hildemann SK; Homann D
    Diabetes; 2012 Feb; 61(2):436-46. PubMed ID: 22210319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4-CXCL10 Axis.
    Wu X; Cheong LY; Yuan L; Jin L; Zhang Z; Xiao Y; Zhou Z; Xu A; Hoo RL; Shu L
    Adv Sci (Weinh); 2024 Aug; 11(30):e2308461. PubMed ID: 38884133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
    Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes.
    Lundberg M; Krogvold L; Kuric E; Dahl-Jørgensen K; Skog O
    Diabetes; 2016 Oct; 65(10):3104-10. PubMed ID: 27422384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.